Cara Therapeutics Inc. (CARA) Financial Statements (2024 and earlier)

Company Profile

Business Address 400 ATLANTIC STREET, SUITE 500
STAMFORD, CT 06901
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:100,758156,749236,789251,490218,165182,779
Cash and cash equivalents51,77563,74113,45331,68318,30515,081
Short-term investments   153,582149,242136,701146,302
Other undisclosed cash, cash equivalents, and short-term investments48,98393,00869,75470,56563,15921,396
Restricted cash and investments 408408   361
Receivables4,0174,4531,1522,0641,7871,590
Inventory, net of allowances, customer advances and progress billings2,8212,3832,584   
Inventory2,8212,3832,584   
Prepaid expense8,15416,2672,51912,0768,8634,805
Other undisclosed current assets  (11,350)(69,754)(70,565)(63,159)(21,396)
Total current assets:116,158168,910173,290195,065165,656168,139
Noncurrent Assets
Operating lease, right-of-use asset4,8641,5512,9734,2793,036
Property, plant and equipment3,322426631840700880
Long-term investments and receivables   69,75470,56563,15921,396
Long-term investments   69,75470,56563,15921,396
Restricted cash and investments1,500 408408408408
Other undisclosed noncurrent assets  11,350    
Total noncurrent assets:9,68613,32773,76676,09267,30322,684
TOTAL ASSETS:125,844182,237247,056271,157232,959190,823
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:25,59221,54015,86116,88119,66513,622
Employee-related liabilities4,9594,9553,2932,370
Accounts payable11,5839,6045,6254,8939,1004,371
Accrued liabilities9,6666,736629839635802
Other undisclosed accounts payable and accrued liabilities4,3435,2004,6486,1946,6376,079
Deferred revenue     22,262
Debt     967 
Contract with customer, liability26,825
Other undisclosed current liabilities 1,9181,7551,602  
Total current liabilities:25,59223,45817,61618,48342,89440,447
Noncurrent Liabilities
Long-term debt and lease obligation:   1,9183,6733,352 
Liabilities, other than long-term debt6,088    16,746
Contract with customer, liability15,184
Deferred rent credit      1,562
Restructuring reserve      
Operating lease, liability6,088 1,9183,6733,352
Other undisclosed noncurrent liabilities37,079     
Total noncurrent liabilities:43,167 3,8367,3463,35216,746
Total liabilities:68,75923,45821,45225,82946,24657,193
Equity
Equity, attributable to parent57,085158,779227,522249,001186,713133,630
Common stock545353504739
Additional paid in capital742,036726,630708,585641,195587,223428,059
Accumulated other comprehensive income (loss)(260)(1,672)(358)73170(114)
Accumulated deficit(684,745)(566,232)(480,758)(392,317)(400,727)(294,354)
Total equity:57,085158,779227,522249,001186,713133,630
Other undisclosed liabilities and equity   (1,918)(3,673)  
TOTAL LIABILITIES AND EQUITY:125,844182,237247,056271,157232,959190,823

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues20,96841,86723,028135,08219,88613,469
Cost of revenue
(Cost of Goods and Services Sold)
 (526)(34)    
Other undisclosed gross profit      
Gross profit:20,44241,83323,028135,08219,88613,469
Operating expenses(142,463)(129,402)(112,111)(129,697)(131,565)(90,851)
Other undisclosed operating income52634    
Operating income (loss):(121,495)(87,535)(89,083)5,385(111,679)(77,382)
Nonoperating income
(Other Nonoperating income)
3,5862,0616422,3344,4902,980
Income (loss) from continuing operations before income taxes:(117,909)(85,474)(88,441)7,719(107,189)(74,402)
Income tax benefit    691816389
Income (loss) from continuing operations:(117,909)(85,474)(88,441)8,410(106,373)(74,013)
Income (loss) before gain (loss) on sale of properties:(88,441)8,410(106,373)(74,013)
Other undisclosed net loss(604)     
Net income (loss) available to common stockholders, diluted:(118,513)(85,474)(88,441)8,410(106,373)(74,013)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(118,513)(85,474)(88,441)8,410(106,373)(74,013)
Other comprehensive income (loss)1,412(1,314)(431)(97)284(44)
Other undisclosed comprehensive income      
Comprehensive income (loss):(117,101)(86,788)(88,872)8,313(106,089)(74,057)
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(117,101)(86,788)(88,872)8,313(106,089)(74,057)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: